Annals of Thoracic Medicine
BRIEF REPORT
Year
: 2022  |  Volume : 17  |  Issue : 4  |  Page : 189--192

Lung cancer screening in the gulf: Rationale and recommendations


Sami M Bennji1, B Jayakrishnan1, Adil H Al-Kindi2, Issa Al-Jahdhami3, Zamzam Al-Hashami1 
1 Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, Oman
2 Division of Cardiothoracic Surgery, Sultan Qaboos University Hospital, Muscat, Oman
3 Department of Medicine, Armed Forces Hospital, Muscat, Oman

Correspondence Address:
Dr. Sami M Bennji
Sultan Qaboos Comprehensive Cancer Care and Research Center, P. O. Box: 566; PC: 123, Muscat
Oman

Lung cancer is the leading cause of cancer-related death worldwide among both men and women. Although advances in therapy have been made, the 5-year survival rates for lung cancer remain poor, ranging from 10% to 20%. One of the main reasons is late presentation, as only 25% of patients are amenable to cure at the time of presentation. Therefore, the emphasis on lung cancer screening (LCS) is growing with the current evidence that has shown benefits with low-dose computed tomography scan of the chest in high-risk populations. LCS remains a debated topic in Gulf Cooperation Council (GCC) countries, possibly due to a lack of local experience. In this article, we explore the rationale and give recommendations on the best approach for LCS in GCC.


How to cite this article:
Bennji SM, Jayakrishnan B, Al-Kindi AH, Al-Jahdhami I, Al-Hashami Z. Lung cancer screening in the gulf: Rationale and recommendations.Ann Thorac Med 2022;17:189-192


How to cite this URL:
Bennji SM, Jayakrishnan B, Al-Kindi AH, Al-Jahdhami I, Al-Hashami Z. Lung cancer screening in the gulf: Rationale and recommendations. Ann Thorac Med [serial online] 2022 [cited 2023 Feb 2 ];17:189-192
Available from: https://www.thoracicmedicine.org/article.asp?issn=1817-1737;year=2022;volume=17;issue=4;spage=189;epage=192;aulast=Bennji;type=0